RT Journal Article
SR Electronic
T1 Effect of evacuation of Japanese residents from Wuhan, China, on preventing transmission of novel coronavirus infection: a modelling study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.06.17.20133520
DO 10.1101/2020.06.17.20133520
A1 Asai, Yusuke
A1 Tsuzuki, Shinya
A1 Kutsuna, Satoshi
A1 Hayakawa, Kayoko
A1 Ohmagari, Norio
YR 2020
UL http://medrxiv.org/content/early/2020/06/18/2020.06.17.20133520.abstract
AB Objective In late January 2020, the Japanese government carried out three evacuations by aircraft from Wuhan, China, to avoid further cases of coronavirus disease 2019 (COVID-19) among Wuhan’s Japanese residents. Evacuation by aircraft may be an effective countermeasure against outbreaks of infectious diseases, but evidence of its effect is scarce. This study estimated how many COVID-19 cases were prevented among the Japanese residents of Wuhan by the evacuation countermeasure.Results Eleven imported COVID-19 cases were reported on Feb 1 from among the total 566 evacuees who returned to Japan. In the case of no evacuations being made, the cumulative number of COVID-19 cases among Wuhan’s Japanese residents was estimated to reach 25 (95% CI [20, 29]) on Feb 8 and 34 (95% CI [28, 40]) on Feb 15. A 1-week delay in the evacuation might be led to 14 additional cases and a 2-week delay to 23 additional cases. Evacuation by aircraft can contribute substantially to reducing the number of infected cases in the initial stage of the outbreak.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funder supported this study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Ethics Committee of National Center for Global Health and Medicine, Tokyo, Japan (Approval Number NCGM-G-003475-00).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.COVID-19coronavirus disease 2019MHLWMinistry of Health, Labour and Welfare JapanWHOWorld Health OrganizationNCGMNational Center for Global Health and Medicine, Tokyo, JapanSEMAIRsusceptible-exposed-moderate-asymptomatic-infectious-recoveredSEIRsusceptible-exposed-infectious-recoveredCIconfidence interval.